| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
,
*
Center for Cancer Research and Departments of
Biology and
Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139; and
Department of Pharmacology and Molecular Sciences and Department of Neuroscience, Johns Hopkins Medical School, Baltimore, MD 21205
Sanglifehrin A (SFA) is a novel immunosuppressive natural product that binds to cyclophilin but is structurally distinct from cyclosporin A (CsA). We have investigated the cellular and molecular mechanisms of the action of SFA in T lymphocytes. We show that SFA inhibits T cell proliferation induced by IL-2 with an IC50 of 200 nM. Distinct from CsA, which also binds to cyclophilin, SFA does not affect calcium-dependent IL-2 production, although SFA enhanced IL-2 gene transcription in the same cells. SFA blocks T cell proliferation induced by IL-2 in G1 with no appreciable effect on IL-2 receptor expression in a manner similar to that of the immunosuppressant rapamycin. Unlike rapamycin, however, SFA has no effect on the phosphorylation or enzymatic activity of p70s6k kinase, distinguishing SFA from rapamycin in their mode of action. SFA inhibits hyperphosphorylation of Rb and the activity of cyclin E-cyclin-dependent kinase 2 on IL-2 signaling. These results suggest that SFA has a novel mode of action in comparison with CsA, FK506, and rapamycin, and that its use as a molecular probe may lead to the discovery of a novel target involved in T cell activation.
This article has been cited by other articles:
|
|
 |
|
  J. Kallen, R. Sedrani, G. Zenke, and J. Wagner Structure of Human Cyclophilin A in Complex with the Novel Immunosuppressant Sanglifehrin A at 1.6 A Resolution J. Biol. Chem., June 10, 2005; 280(23): 21965 - 21971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, F. Erdmann, R. Baumgrass, M. Schutkowski, and G. Fischer Unexpected Side Chain Effects at Residue 8 of Cyclosporin A Derivatives Allow Photoswitching of Immunosuppression J. Biol. Chem., February 11, 2005; 280(6): 4842 - 4850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Sundrud, V. J. Torres, D. Unutmaz, and T. L. Cover Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion PNAS, May 18, 2004; 101(20): 7727 - 7732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Woltman, N. Schlagwein, S. W. van der Kooij, and C. van Kooten The Novel Cyclophilin-Binding Drug Sanglifehrin A Specifically Affects Antigen Uptake Receptor Expression and Endocytic Capacity of Human Dendritic Cells J. Immunol., May 15, 2004; 172(10): 6482 - 6489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Allen, Y. Zheng, L. Gardner, M. Safford, M. R. Horton, and J. D. Powell The Novel Cyclophilin Binding Compound, Sanglifehrin A, Disassociates G1 Cell Cycle Arrest from Tolerance Induction J. Immunol., April 15, 2004; 172(8): 4797 - 4803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Steinschulte, T. Taner, A. W. Thomson, G. Bein, and H. Hackstein Cutting Edge: Sanglifehrin A, a Novel Cyclophilin-Binding Immunosuppressant Blocks Bioactive IL-12 Production by Human Dendritic Cells J. Immunol., July 15, 2003; 171(2): 542 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Clarke, G. P. McStay, and A. P. Halestrap Sanglifehrin A Acts as a Potent Inhibitor of the Mitochondrial Permeability Transition and Reperfusion Injury of the Heart by Binding to Cyclophilin-D at a Different Site from Cyclosporin A J. Biol. Chem., September 13, 2002; 277(38): 34793 - 34799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pahl, M. Zhang, K. Torok, H. Kuss, U. Friedrich, Z. Magyar, J. Szekely, K. Horvath, K. Brune, and I. Szelenyi Anti-Inflammatory Effects of a Cyclosporine Receptor-Binding Compound, D-43787 J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 738 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-H. Zhang, H.-D. Youn, and J. O. Liu Inhibition of Cell Cycle Progression by the Novel Cyclophilin Ligand Sanglifehrin A Is Mediated through the NFkappa B-dependent Activation of p53 J. Biol. Chem., November 16, 2001; 276(47): 43534 - 43540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zenke, U. Strittmatter, S. Fuchs, V. F. J. Quesniaux, V. Brinkmann, W. Schuler, M. Zurini, A. Enz, A. Billich, J.-J. Sanglier, et al. Sanglifehrin A, a Novel Cyclophilin-Binding Compound Showing Immunosuppressive Activity with a New Mechanism of Action J. Immunol., June 15, 2001; 166(12): 7165 - 7171. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
